U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07695285) titled 'Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial' on July 06.

Brief Summary: This prospective, randomized controlled trial aims to investigate the perioperative use of lemborexant, an orexin receptor antagonist, for reducing postoperative delirium (POD) in elderly patients undergoing general anesthesia.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Postoperative Delirium

Intervention: DRUG: Lemborexant Pill

The intervention group will take Lemborexant tablets four times during the perioperative period

DRUG: Placebo tablet

The control gr...